GE will demonstrate at RSNA 2014 its newly FDA-approved tomosynthesis solution.
GE to showcase at RSNA 2014 its Revolution family of CT scanners.
GE to demonstrate at RSNA 2014 ultrasound hardware and software.
GE Healthcare will debut at RSNA 2014 their SIGNA PET/MR system.
Where did tomosynthesis come from and where is it going? Here, a tomosynthesis pioneer discusses its evolution.
GE’s SenoClaire breast tomosynthesis solution will join Hologic, the only other vendor with FDA approval for 3D mammography.
As breast imaging technology advances, providers are looking to vendors to help meet their needs. Find out here which vendors are favored.
With patient satisfaction an increasing concern, radiology vendors and facilities are focused on improving the imaging experience.
GE Healthcare’s Vizamyl, for PET imaging of the brain to estimate beta amyloid neuritic plaque density in cognitively impaired adults, introduced in 7 markets.
The FDA has approved GE Healthcare’s Q.Clear, a technology that GE says improves accuracy when assessing a patient’s response to treatment.